Sadly the Papers Finally Showed the Covid mRNA Vaccines Triggered Myocarditis in all Age Groups.

Sorry you didn't pick up on that. They didn't want you to know. They hid it. PS THEY ALSO LIED ABOUT THE MYOCARDITIS RISK FROM Actual COVID (it was neglible/non existant) They also lied about the HOSPITALIZATION RISK (also untrue, they counted vaccinated in their "unvaccinated" numbers). 620% Higher Risk of Myocarditis After mRNA COVID Vaccines A peer-reviewed study of 9.2 million South Koreans published in Nature Communications uncovered a 620% increased risk of myocarditis and 175% higher risk of pericarditis following mRNA COVID-19 vaccination. Researchers also noted increased risks of several autoimmune conditions, especially after booster doses. -------- PS Israel warned the CDC in April 2021 that it was affecting young males in high numbers. And they did nothing, they still let it roll out in May 2021. Suddenly, young men started coming into the Child Hospitals ICUs after they came on the market for that age group. Find the News stations coverage. It's out there. Go search up the National Geographic Story of the boy who got it. NOTE HOW THEY ALWAYS FRAMED THESE MYOCARDITS IN KIDS AS RARE, THEY WERE COVERING THEIR TRACKS EVEN THEN.... ------------ "14-year-old Aiden Ekanayake was allegedly “excited” to get the COVID jab on May 12, 2021, the first day it became available to children his age. Aiden’s mom, Emily Jo, was also excited for her son, who was in an age group of individuals at low risk of dying from COVID, to receive the experimental mRNA jab. Emily Jo was actually so proud of her decision to have her 14-yr-old son vaccinated that she took a photo of him in their vehicle on the way home from getting jabbed with a proof of vaccination card in his hand. https://twitter.com/eekymom/status/1392504137338740737?s=20&t=hfxOgTnJDbLMEw0muXizZA ------------- If you want to learn more, the Japanese also did LARGE STUDIES. And Dr. Peter McCullough, former Editor of 2 Cardiolgy Journals has repeatedly reported on this.

Comments

Post a Comment

Popular posts from this blog

The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147-receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease

  bioRxiv preprint doi: https://doi.org/10.1101/2020.12.21.423721 ; this version posted July 20, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. Original research article The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147-receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease Elisa Avolio, PhD 1 ; Michele Carrabba, PhD 1 ; Rachel Milligan, PhD 2 ; Maia Kavanagh Williamson, PhD 2 ; Antonio P Beltrami, MD PhD 3 ; Kapil Gupta, PhD 4 ; Karen T Elvers, PhD 5 ; Monica Gamez, PhD 1 ; Rebecca Foster, PhD 1 ; Kathleen Gillespie, PhD 1 ; Fergus Hamilton, PhD 1 ; David Arnold, PhD 1 ; Imre Berger, PhD 4,6 ; Massimo Caputo, MD 1 ; Andrew D Davidson, PhD 2 ; Darryl Hill, PhD 2 ; Paolo Madeddu, MD 1 (1) Bristol Medical School, Translational Health...
Read more

A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products

A Report on Myocarditis Adverse Events in the U.S. Vaccine Adverse Events Reporting System (VAERS) in Association with COVID-19 Injectable Biological Products 10/07/2021 Web Internet Archive Capture Abstract Following the global rollout and administration of the Pfizer Inc./BioNTech BNT162b2 and Moderna mRNA-1273 vaccines on December 17, 2020, in the United States, and of the Janssen Ad26.COV2.S product on April 1st, 2021, in an unprecedented manner, hundreds of thousands of individuals have reported adverse events (AEs) using the Vaccine Adverse Events Reports System (VAERS). We used VAERS data to examine cardiac AEs, primarily myocarditis, reported following injection of the first or second dose of the COVID-19 injectable products. Myocarditis rates reported in VAERS were significantly higher in youths between the ages of 13 to 23 (p
Read more